PHOENIX, Ariz. July 29, 2011 Mattress Firm, a leading specialty mattress retailer with more than 720 stores nationwide, is committed to supporting the fight against pancreatic cancer by raising funds for clinical trials through the Translational Genomics Research Institute (TGen) globalCure initiative.
GlobalCure is a TGen-led alliance of the world's foremost scientists, physicians and advocates in the fight to find a cure for pancreatic cancer, the nation's fourth leading cause of cancer death.
Mattress Firm is following in the footsteps of Scottsdale resident Roger Magowitz, who for nearly a decade has championed research into finding a cure for pancreatic cancer, the disease that took the life of his mother, Seena, in 2001.
Magowitz, a longtime member of the bedding industry, has enlisted the Houston-based company's Mattress Firm Foundation to join the fight against pancreatic cancer by supporting globalCure.
"Roger Magowitz was quick to impress upon us all the importance of funding research and raising awareness for this deadly disease," said Mattress Firm President and CEO Steve Stagner. "His transfer of enthusiasm to us really hit home with our executive team, and ultimately with the rest of our company."
As a result, Mattress Firm Foundation has named TGen as its "charitable partner," specifically funding the research and clinical trials conducted by globalCure.
"It is a most generous tribute to my late mother that the Mattress Firm Foundation has elected to join the fight against pancreatic cancer, specifically through funding globalCure," said Roger Magowitz, President of the Seena Magowitz Foundation. "Pancreatic cancer is a disease that we believe can eventually be cured and soon."
Through a promotional partnership with Simmons Bedding Co. earlier this year and corporate support of the cause Mattress Firm Foundation has already raised more than $400,000 to directly support the clinical
|Contact: Steve Yozwiak|
The Translational Genomics Research Institute